WWW.JNEUROSCI.ORG
-
Life science instruments for behavioral neuroscience research
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (56)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furtinger, S.
Right arrow Articles by Sperk, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furtinger, S.
Right arrow Articles by Sperk, G.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2001, 21(15):5804-5812

Plasticity of Y1 and Y2 Receptors and Neuropeptide Y Fibers in Patients with Temporal Lobe Epilepsy

Sabine Furtinger1, Susanne Pirker1, Thomas Czech3, Christoph Baumgartner4, Gerhard Ransmayr2, and Günther Sperk1

Departments of 1 Pharmacology and 2 Neurology, University of Innsbruck, A-6020 Innsbruck, Austria, and Departments of 3 Neurosurgery and 4 Neurology, University of Vienna, A-1090 Vienna, Austria

Marked expression of neuropeptide Y (NPY) and its Y2 receptors in hippocampal mossy fibers has been reported in animal models of epilepsy. Because NPY can suppress glutamate release by activating presynaptic Y2 receptors, these changes have been proposed as an endogenous protective mechanism. Therefore, we investigated whether similar changes in the NPY system may also take place in human epilepsy. We investigated Y1 and Y2 receptor binding and NPY immunoreactivity in hippocampal specimens that were obtained at surgery from patients with temporal lobe epilepsy and in autopsy controls. Significant increases in Y2 receptor binding (by 43-48%) were observed in the dentate hilus, sectors CA1 to CA3, and subiculum of specimens with, but not in those without, hippocampal sclerosis. On the other hand, Y1 receptor binding was significantly reduced (by 62%) in the dentate molecular layer of sclerotic specimens. In the same patients, the total lengths of NPY immunoreactive (NPY-IR) fibers was markedly increased (by 115-958%) in the dentate molecular layer and hilus, in the stratum lucidum of CA3, and throughout sectors CA1 to CA3 and the subiculum, as compared with autopsies. In nonsclerotic specimens, increases in lengths of NPY-IR fibers were more moderate and statistically not significant. NPY mRNA was increased threefold in hilar interneurons of sclerotic and nonsclerotic specimens. It is suggested that abundant sprouting of NPY fibers, concomitant upregulation of Y2 receptors, and downregulation of Y1 receptors in the hippocampus of patients with Ammon's horn sclerosis may be endogenous anticonvulsant mechanisms.

Key words: NPY; hippocampus; limbic system; dentate gyrus; presynaptic receptors; Ammon's horn sclerosis; neuropeptides; seizures


Copyright © 2001 Society for Neuroscience  0270-6474/01/21155804-09$05.00/0


This article has been cited by other articles:


Home page
NeurologyHome page
M. Thom, L. Martinian, C. Catarino, M. Yogarajah, M. J. Koepp, L. Caboclo, and S. M. Sisodiya
Bilateral reorganization of the dentate gyrus in hippocampal sclerosis: A postmortem study
Neurology, September 29, 2009; 73(13): 1033 - 1040.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. E. Benarroch
Neuropeptide Y: Its multiple effects in the CNS and potential clinical significance
Neurology, March 17, 2009; 72(11): 1016 - 1020.
[Full Text] [PDF]


Home page
BrainHome page
F. Noe, A.-H. Pool, J. Nissinen, M. Gobbi, R. Bland, M. Rizzi, C. Balducci, F. Ferraguti, G. Sperk, M. J. During, et al.
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy
Brain, June 1, 2008; 131(6): 1506 - 1515.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Brill, M. Lee, S. Zhao, R. D. Fernald, and J. R. Huguenard
Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.
J. Neurosci., June 21, 2006; 26(25): 6813 - 6822.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Jamali, F. Bartolomei, A. Robaglia-Schlupp, A. Massacrier, J.-C. Peragut, J. Regis, H. Dufour, R. Ravid, P. Roll, S. Pereira, et al.
Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex
Brain, March 1, 2006; 129(3): 625 - 641.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Tu, O. Timofeeva, Y. Jiao, and J. V. Nadler
Spontaneous Release of Neuropeptide Y Tonically Inhibits Recurrent Mossy Fiber Synaptic Transmission in Epileptic Brain
J. Neurosci., February 16, 2005; 25(7): 1718 - 1729.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. Li, A. E. Bandrowski, and D. A. Prince
Cortical Injury Affects Short-Term Plasticity of Evoked Excitatory Synaptic Currents
J Neurophysiol, January 1, 2005; 93(1): 146 - 156.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Gabriel, M. Njunting, J. K. Pomper, M. Merschhemke, E. R. G. Sanabria, A. Eilers, A. Kivi, M. Zeller, H.-J. Meencke, E. A. Cavalheiro, et al.
Stimulus and Potassium-Induced Epileptiform Activity in the Human Dentate Gyrus from Patients with and without Hippocampal Sclerosis
J. Neurosci., November 17, 2004; 24(46): 10416 - 10430.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Richichi, E.-J. D. Lin, D. Stefanin, D. Colella, T. Ravizza, G. Grignaschi, P. Veglianese, G. Sperk, M. J. During, and A. Vezzani
Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus
J. Neurosci., March 24, 2004; 24(12): 3051 - 3059.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Berglund, P. A. Hipskind, and D. R. Gehlert
Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes
Experimental Biology and Medicine, March 1, 2003; 228(3): 217 - 244.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-